Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05003973
Other study ID # A-ER-107-433
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 20, 2021
Est. completion date December 31, 2023

Study information

Verified date August 2021
Source National Cheng Kung University
Contact Yu-Yun Hsu
Phone +886-6-2353535
Email yuht12@mail.ncku.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: The incidence of lower limb lymphedema (LLL) after gynecological cancer surgery with lymphadenectomy is about 10-46%. Lower limb lymphedema results in limited physical mobility and reduced patients' quality of life. A hospital -based complete decongestive therapy has been recommended to patients with LLL, including exercise, manual lymphatic drainage, compression therapy, and skin care. However, the inconvenience of the hospital-based rehabilitation program limit the availability for those patients LLL. Home-based exercise program may be feasible instead of the hospital-based program. Few studies have evaluated the effectiveness of the home-based lower extremity exercise on reliving LLL and improving quality of life in patients with LLL. Research Purposes: The main purpose of the study is to evaluate the effectiveness of a home-based exercise program for relieving lower extremity lymphedema, including circumference measurement, bioimpedance spectroscopy (BIS), lower limb muscle strength, quality of life related to cancer & LLL, and fatigue. Methods: This study is a two- year project with a single-blind randomized clinical trial. The participants are women with gynecological cancer surgery, aged of 20-75 years and currently have lower extremity lymphedema. A sample of 76 participants will be stratified randomly assigned to an experimental group or a control group. The experimental group is to carry out a home-based anti-resistance exercise with elastic band other than a routine care of complex decongestive physiotherapy; while the control group is to carry out a routine care of complex decongestive physiotherapy. The home-based program is a 12-week exercise program. Data collections will be conducted before exercise (Baseline), during exercise (second months), and exercise program after completion. Measures includes (1) Physical examination: limb leg circumference measurement, bioimpedance spectroscopy (BIS), lower limb muscle strength, (2) Questionnaires: Functional status of lymphatic edema of LLL, fatigue, and EORTC-QLQ-C30. Anticipated Outcomes: Findings from this study could provide a reference of home-based exercise guideline and be integrated into the care of activities for women following gynecological surgery with LLL.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date December 31, 2023
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 75 Years
Eligibility Inclusion Criteria: - women with gynecological cancer surgery - aged of 20-75 years - currently have lower extremity lymphedema. Exclusion Criteria: - heart failure - kidney failure - DVT - limb surgery

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
home-based anti-resistance exercise
It is a 12-week, middle-level, home-based, anti-resistance exercise. Exercise was recommended 1-2 times per day for 15-20 mins per session.
usually care
The leaflet of the lymphedema self-care, including skin care and manual lymphatic drainage

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
National Cheng Kung University

Outcome

Type Measure Description Time frame Safety issue
Primary Limb circumference change from baseline to 3 months Measuring by measuring tape from baseline to 3 months
Primary Edema change from baseline to 3 months Measuring by Bioelectrical Impedance Spectroscopy (BIS)- InBody S10 from baseline to 3 months
Primary Lower limb muscle strength change from baseline to 3 months Measuring by microFET 2 from baseline to 3 months
Primary Functional status of lymphatic edema of LLL change from baseline to 3 months Measuring by Lymphoedema Functioning, Disability and Health Questionnaire for Lower Limb Lymphoedema (Lymph-ICF-LL). It is a 28-item, 0(no problem) to 10(very severe) questionnaire. from baseline to 3 months
Primary Fatigue change from baseline to 3 months Measuring by Chinese Lee Fatigue Scale Short Form (C-LESSF). It is a 7-item, from 0(no fatigue) to 10(very fatigue) questionnaire. from baseline to 3 months
Primary EORTC-QLQ-C30 Measuring by EORTC QLQ C30. It is a 30-item, from 0(no problem) to 10(very severe) questionnaire. from baseline to 3 months
See also
  Status Clinical Trial Phase
Completed NCT03935698 - Physiotherapy Treatment in Women With Dyspareunia Following Gynecological Cancer: a Pilot Study N/A
Completed NCT01831089 - Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors Phase 1
Completed NCT01703585 - Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
Completed NCT04694508 - Intraoperative Music Therapy in Gynecological Oncology N/A
Recruiting NCT03714581 - Laser Therapy Following Radiotherapy for Gynecological Cancer N/A
Recruiting NCT03740503 - Genomic Investigation of Unusual Responders
Completed NCT02169908 - Analysis of Chronic Neuropathic Pain Markers in Patients Treated With Oxaliplatin N/A
Recruiting NCT05028504 - A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer Phase 2
Completed NCT02026687 - Recovery and Analgesia After Surgery for Gynecological Cancer Phase 4
Not yet recruiting NCT06039306 - Perioperative Immunonutrition Under Enhanced Recovery After Surgery N/A
Active, not recruiting NCT04341480 - The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19
Recruiting NCT04236362 - A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer Phase 1/Phase 2
Recruiting NCT02906943 - Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
Completed NCT03553784 - Low-Intensity CBT for Gynaecological Cancer Survivors N/A